Alvin S. Tan

Selwyn Street And Pembroke Street
Hamilton, WKO 3204, New Zealand

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Intensive multimodal ketogenic metabolic therapy in glioblastoma: A clinical trial.

Intensive multimodal ketogenic metabolic therapy in glioblastoma: A clinical trial.

Journal: Neuro-oncology advances

Published: April 14, 2026

Eight-year outcomes of testosterone suppression plus enzalutamide or a non-steroidal anti-androgen for metastatic, hormone-sensitive prostate cancer (ENZAMET; ANZUP 1304).

Eight-year outcomes of testosterone suppression plus enzalutamide or a non-steroidal anti-androgen for metastatic, hormone-sensitive prostate cancer (ENZAMET; ANZUP 1304).

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: April 01, 2026

Real-World Outcomes in Advanced Clear Cell Renal Cell Carcinoma: A Retrospective Analysis Comparing New Zealand and Australian Cohorts.

Real-World Outcomes in Advanced Clear Cell Renal Cell Carcinoma: A Retrospective Analysis Comparing New Zealand and Australian Cohorts.

Journal: JCO global oncology

Published: March 06, 2026

Radiographic Progression Without Prostate-specific Antigen Progression in Metastatic Hormone-sensitive Prostate Cancer: A Retrospective Analysis of the ENZAMET Trial (ANZUP 1304).

Radiographic Progression Without Prostate-specific Antigen Progression in Metastatic Hormone-sensitive Prostate Cancer: A Retrospective Analysis of the ENZAMET Trial (ANZUP 1304).

Journal: European urology oncology

Published: November 10, 2025

Pembrolizumab-related toxicity in patients with advanced melanoma.

Pembrolizumab-related toxicity in patients with advanced melanoma.

Journal: The New Zealand medical journal

Published: June 26, 2025

Process of development of decentralised clinical trial methodology for cancer clinical trials in Aotearoa New Zealand.

Process of development of decentralised clinical trial methodology for cancer clinical trials in Aotearoa New Zealand.

Journal: The New Zealand medical journal

Published: December 12, 2024

Combined phosphorus-32 implantation and chemotherapy versus chemotherapy alone for locally advanced pancreatic cancer: a propensity score-weighted landmark analysis.

Combined phosphorus-32 implantation and chemotherapy versus chemotherapy alone for locally advanced pancreatic cancer: a propensity score-weighted landmark analysis.

Journal: Gastrointestinal endoscopy

Published: November 09, 2024

Real-World Outcomes of Immunotherapy for Melanoma Brain Metastases in New Zealand.

Real-World Outcomes of Immunotherapy for Melanoma Brain Metastases in New Zealand.

Journal: JCO oncology practice

Published: July 25, 2024

Proton pump inhibition to prevent delayed chemotherapy-induced nausea and vomiting in patients receiving adjuvant or neoadjuvant breast cancer chemotherapy: a phase II, randomised double-blind crossover trial (PantoCIN).

Proton pump inhibition to prevent delayed chemotherapy-induced nausea and vomiting in patients receiving adjuvant or neoadjuvant breast cancer chemotherapy: a phase II, randomised double-blind crossover trial (PantoCIN).

Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

Published: January 29, 2024

Testosterone suppression plus enzalutamide versus testosterone suppression plus standard antiandrogen therapy for metastatic hormone-sensitive prostate cancer (ENZAMET): an international, open-label, randomised, phase 3 trial.

Testosterone suppression plus enzalutamide versus testosterone suppression plus standard antiandrogen therapy for metastatic hormone-sensitive prostate cancer (ENZAMET): an international, open-label, randomised, phase 3 trial.

Journal: The Lancet. Oncology

Published: December 05, 2022

Twelve ESMO Congress 2022 breakthroughs: practicing oncologists' perceptions and potential application on presented data.

Twelve ESMO Congress 2022 breakthroughs: practicing oncologists' perceptions and potential application on presented data.

Journal: ESMO open

Published: November 04, 2022

Feasibility and Safety of a Combined Metabolic Strategy in Glioblastoma Multiforme: A Prospective Case Series.

Feasibility and Safety of a Combined Metabolic Strategy in Glioblastoma Multiforme: A Prospective Case Series.

Journal: Journal of oncology

Published: April 23, 2022

Showing 1-12 of 20

Last Updated: 09/26/2026